Review
Version 1
Preserved in Portico This version is not peer-reviewed
Molecular Pathways in Staphylococcus Aureus Endocarditis: a Systematic Review
Version 1
: Received: 31 December 2022 / Approved: 4 January 2023 / Online: 4 January 2023 (02:43:20 CET)
How to cite: Nappi, F.; Avtaar Singh, S. S. Molecular Pathways in Staphylococcus Aureus Endocarditis: a Systematic Review. Preprints 2023, 2023010045. https://doi.org/10.20944/preprints202301.0045.v1 Nappi, F.; Avtaar Singh, S. S. Molecular Pathways in Staphylococcus Aureus Endocarditis: a Systematic Review. Preprints 2023, 2023010045. https://doi.org/10.20944/preprints202301.0045.v1
Abstract
Staphylococci sp. have become the primary pathogens implicated in infective endocarditis, especially within high-income nations. Coupled with the increasing burden of healthcare with aging populations and the protracted course the infections may take, these infections contribute to a significant challenge for healthcare. A systematic review was conducted using relevant search criteria from PubMed, Ovid’s version of MEDLINE, and EMBASE, and data were tabulated from randomized controlled trials (RCT), observational cohort studies, meta-analysis, and basic research articles. The review was registered with the OSF register of systematic reviews and followed the PRISMA reporting guidelines. 35 studies met the inclusion criteria and were included in the final systematic review. The role of Staphylococcus aureus and its interaction with the protective shield and host protection functions is identified and highlighted in several studies. The interaction between infective endocarditis pathogens, vascular endothelium, and blood constituents is also explored giving rise to the potential use of antiplatelets as preventative and/or curative agents. Several factors allow Staphylococcus aureus infections to proliferate within the host with numerous promoting and perpetuating agents. The complex interaction with the hosts' innate immunity also potentiates its virulence. Ameliorating these molecular pathways may serve as a therapeutic avenue for the prevention and treatment of these infections in the near future.
Keywords
infective endocarditis; staphylococcus aureus infection; staphylococcus aureus immunity; staphylococcus aureus cytotoxin; biofilm resistance
Subject
Medicine and Pharmacology, Cardiac and Cardiovascular Systems
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment